Recursion Announces $150 Million Private Placement to New and Existing Investors, led by Kinnevik AB
SALT LAKE CITY, Oct. 25, 2022 /PRNewswire/ — Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced today that it has entered into a stock purchase agreement for the sale of an aggregate of approximately 15.3 million shares of its Class A common stock in a private placement, led by Kinnevik […]